Krüppel-like factor 1 mutations and expression of hemoglobins F and A2 in homozygous hemoglobin E syndrome

Annals of Hematology

Volumn 94, Issue 7, 2015, Pages 1093-1098

  Tepakhan, Wanicha ^a   Yamsri, Supawadee ^a   Fucharoen, Goonnapa ^a   Sanchaisuriya, Kanokwan ^a   Fucharoen, Supan ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Hemoglobin A2; Hemoglobin F; Homozygous hemoglobin E; KLF1 mutations

Indexed keywords

ERYTHROID KRUPPEL-LIKE FACTOR; HEMOGLOBIN A2; HEMOGLOBIN E; HEMOGLOBIN F; KRUPPEL LIKE FACTOR;

BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HEMOGLOBINOPATHIES; HOMOZYGOTE; HUMAN; SYNDROME;

FETAL HEMOGLOBIN; GENE EXPRESSION REGULATION; HEMOGLOBIN A2; HEMOGLOBIN E; HEMOGLOBINOPATHIES; HOMOZYGOTE; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; SYNDROME;

EID: 84937511908     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-015-2335-x     Document Type: Article

References (27)

1. Tritipsombut J, Sanchaisuriya K, Phollarp P, Bouakhasith D, Sanchaisuriya P, Fucharoen G, Fucharoen S, Schelp FP (2012) Micromapping of thalassemia and hemoglobinopathies in diferent regions of northeast Thailand and Vientiane, Laos People’s Democratic Republic. Hemoglobin 36:47–56
2. Rees DC, Styles L, Vichinsky EP, Clegg JB, Weatherall DJ (1998) The hemoglobin E syndromes. Ann N Y Acad Sci 850:334–343
3. Sanchaisuriya K, Fucharoen G, Sae-ung N, Jetsrisuparb A, Fucharoen S (2003) Molecular and hematologic features of hemoglobin E heterozygotes with different forms of α-thalassemia in Thailand. Ann Hematol 82:612–616
4. Fucharoen G, Trithipsombat J, Sirithawee S, Yamsri S, Changtrakul Y, Sanchaisuriya K, Fucharoen S (2006) Molecular and hematological profiles of hemoglobin EE disease with different forms of α-thalassemia. Ann Hematol 85:450–454
5. Nuntakarn L, Fucharoen S, Fucharoen G, Sanchaisuriya K, Jetsrisuparb A, Wiangnon S (2009) Molecular, hematological and clinical aspects of thalassemia major and thalassemia intermedia associated with Hb E-β-thalassemia in northeast Thailand. Blood Cells Mol Dis 42:32–35
6. Chaibunruang A, Karnpean R, Fucharoen G, Fucharoen S (2014) Genetic heterogeneity of hemoglobin AEBart’s disease: a large cohort data from a single referral center in northeast Thailand. Blood Cells Mol Dis 52:176–180
7. Chaibunruang A, Fucharoen G, Jetsrisuparb A, Fucharoen S (2011) Hemoglobin Lepore EF Bart’s disease: a molecular, hematological, and diagnostic aspects. Ann Hematol 90:1337–1340
8. 2, E and F in various hemoglobin E related disorders. Blood Cells Mol Dis 48:11–16
9. Uda M, Galanello R, Sanna S, Lettre G, Sankaran VG, Chen W, Busanero F, Maschio A, Albai G, Piras MG, Sestu N, Lai S, Di M, Mulas A, Crisponi L, Nailza S, Asunis I, Delana M, Nagaraja R, Persen L, Satta S, Cipollina MD, Sollaina C, Moi P, Hirschhorn JN, Orkin SH, Abecasis GR, Schessinger D, Cao A (2008) Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc Natl Acad Sci U S A 105:1620–1625
10. Wahlberg K, Jiang J, Rooks H, Jawaid K, Matsuda F, Yamaguchi M, Lathrop M, Thein SL, Best S (2009) The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells. Blood 114:1254–1262
11. Siatecka M, Bieker JJ (2011) The multifunctional role of EKLF/KLF1 during erythropoiesis. Blood 118:2044–2054
12. Zhou D, Liu K, Sun CW, Pawlik KM, Townes TM (2010) KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching. Nat Genet 42:742–744
13. Borg J, Papadopoulos P, Georgitsi M, Gutierrez L, Grech G, Fanis P, Phylactides M, Verkerk AJ, van der Spek PJ, Scerri CA, Cassar W, Galdies R, van ljcken W, Ozgur Z, Gillemans N, Hou J, Bugeja M, Grosveld FG, von Lindern M, Felice AE, Patrinos GP, Phillipsen S (2010) Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat Genet 42:801–805
14. Satta S, Perseu L, Moi P, Asunis I, Cabriolu A, Maccioni L, Demartis FR, Manunza L, Cao A, Galanello R (2011) Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin. Haematologica 96:767–770
15. Radmilovic M, Zukic B, Petrovic MS, Bartsakoulia M, Stankovic B, Kotur N, Dokmanovic L, Georgitsi M, Patrinos GP, Pavlovic S (2013) Functional analysis of a novel KLF1 gene promoter variation associated with hereditary persistence of fetal hemoglobin. Ann Hematol 92:53–58
16. Gallienne AE, Dreau HM, Schuh A, Old JM, Henderson S (2012) Ten novel mutations in the erythroid transcription factor KLF1 gene associated with increased fetal hemoglobin levels in adults. Haematologica 97:340–343
17. Liu D, Zhang X, Yu L, Cai R, Ma X, Zheng C, Zhou Y, Liu Q, Wei X, Lin L, Yan T, Huang J, Mohandas N, An X, Xu X (2014) Erythroid Kruppel-like factor mutations are common in a thalassemia endemic region and ameliorate the clinical and hematological severity of beta-thalassemia. Blood 124:803–811
18. Yamsri S, Sanchaisuriya K, Fucharoen G, Sae-ung N, Ratanasiri T, Fucharoen S (2010) Prevention of severe thalassemia in northeast Thailand: 16 years of experience at a single university center. Prenat Diagn 30:540–546
19. Fucharoen S, Shimizu K, Fukumaki Y (1990) A novel C-T transition within the distal CCAAT motif of the G gamma-globin gene in the Japanese HPFH: implication of factor binding in elevated fetal globin expression. Nucleic Acids Res 18:5245–5253
20. Manvani D, Bieker JJ (2014) KLF1: when less is more. Blood 124:672–673
21. Arnaud L, Saison C, Helias V, Lucien N, Steschenko D, Giarratana MC, Prehu C, Foliguet B, Montout L, de Brevern AG, Francina A, Ripoche P, Fenneteau O, Da Costa L, Peyrard T, Coghlan G, Illurn N, Birgens H, Tamary H, Iolascon A, Delaunay J, Tchernia G, Cartron JP (2010) A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia. Am J Hum Genet 87:721–727
22. Singleton BK, Lau W, Fairweather VS, Burton NM, Wilson MC, Parsons SF, Richardson BM, Trakarnsanga K, Brady RL, Anstee DJ, Frayne J (2011) Mutations in the second zinc finger of human EKLF reduce promoter affinity but give rise to benign and disease phenotypes. Blood 118:3137–3345
23. Singleton BK, Burton NM, Green C, Brady RL, Anstee DJ (2008) Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In (Lu) phenotype. Blood 112:2081–2088
24. Zhou D, Pawlik KM, Ren J, Sun CW, Townes TM (2006) Differential binding of erythroid Krupple-like factor to embryonic/fetal globin gene promoters during development. J Biol Chem 281:16052–16057
25. Wang T, He Y, Zhou JY, Xie XM, Li J, Li R, Liao C, Li DZ (2013) KLF1 gene mutations in Chinese adults with increased fetal hemoglobin. Hemoglobin 37:501–506
26. Viprakasit V, Ekwattanakit S, Riolueang S, Chalaow N, Fisher C, Lower K, Kanno H, Tachavanich K, Bejrachandra S, Saipin J, Juntharaniyom M, Sanpakit K, Tanphaichitr VS, Songdej D, Babbs C, Gibbons RJ, Phillipsen S, Higgs DR (2014) Mutations in Kruppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression. Blood 123:1586–1595
27. Pakdee N, Yamsri S, Fucharoen G, Sanchaisuriya K, Pissard S, Fucharoen S (2014) Variability of hemoglobin F expression in hemoglobin EE disease: hematological and molecular analysis. Blood Cells Mol Dis 53:11–15